Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study (Q36003136)

11 August 2017

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study (English)

1 reference

11 August 2017

1 reference

0 references

0 references

8

Daniel Cattran

1 reference

11 August 2017

Vladimir Tesar

1

1 reference

11 August 2017

Stéphan Troyanov

2

1 reference

11 August 2017

Shubha Bellur

3

1 reference

11 August 2017

Jacobien C Verhave

4

1 reference

11 August 2017

H Terence Cook

5

1 reference

11 August 2017

John Feehally

6

1 reference

11 August 2017

Ian S D Roberts

7

1 reference

11 August 2017

Rosanna Coppo

9

1 reference

11 August 2017

VALIGA study of the ERA-EDTA Immunonephrology Working Group

10

1 reference

11 August 2017

12 February 2015

1 reference

Journal of the American Society of Nephrology

11 August 2017

1 reference

11 August 2017

26

1 reference

11 August 2017

2248-2258

1 reference

11 August 2017

9

1 reference

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Is a legacy effect possible in IgA nephropathy?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Natural history of primary IgA nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Principles for modeling propensity scores in medical research: a systematic literature review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Predicting renal outcome in IgA nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Corticosteroids in patients with IgA nephropathy and severe chronic renal damage

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Steroids and azathioprine in the treatment of IgA nephropathy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Corticosteroids in IgA nephropathy: a randomised controlled trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Estimating equations for glomerular filtration rate in children: laboratory considerations

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Regression of IgA nephropathy: a repeat biopsy study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552116

Can immunosuppressive therapy be useful in IgA nephropathy when the 'Point of No Return' has already been exceeded?

23 September 2018

1 reference

12 December 2020

Remission of proteinuria improves prognosis in IgA nephropathy

1 reference

12 December 2020

Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy

1 reference

12 December 2020

Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy

1 reference

12 December 2020

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults

1 reference

12 December 2020

Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol

1 reference

12 December 2020

IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2014070697

1 reference

11 August 2017

1 reference

11 August 2017

1 reference